Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission-Reference-Cited by-同舟云学术

Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission

Published:2002-02 Issue:2 Volume:116 Page:299-307
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Torelli Giovanni F.,Guarini Anna,Palmieri Gabriella,Breccia Massimo,Vitale Antonella,Santoni Angela,Foa Robin

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2002.03277.x/fullpdf

Reference47 articles.

1. Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. Feasibility of LAK generation in adult patients with active disease and in remission;Adler;Blood,1988

2. Natural killer cells in antiviral defense: function and regulation by innate cytokines;Biron;Annual Reviews of Immunology,1999

3. Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture;Cervantes;Blood,1996

4. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses;Choudhury;Blood,1999

5. CD34 (+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells;Cignetti;Blood,1999

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A NK Cell Odyssey: From Bench to Therapeutics Against Hematological Malignancies;Frontiers in Immunology;2022-04-14

2. Impairment of NK Cell Mediated Immune Surveillance Against Acute Myeloid Leukemia;Turkish Journal of Oncology;2022

3. Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self;Cytotherapy;2020-07

4. Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells;Frontiers in Immunology;2019-10-11

5. Cellular therapy: Adoptive immunotherapy with expanded natural killer cells;Immunological Reviews;2019-07